Oncology
5 drugs are in development for Cholangiocarcinoma.
- Companies
- 4
- Clinical trials
- 34
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Cholangiocarcinoma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| MGC028 | MACROGENICS INC (MGNX) |
Phase 1/Phase 2(4)
About this indication
Cholangiocarcinoma context
Oncology·MeSH: Cholangiocarcinoma (D018281)
Also known as: Carcinoma, Cholangiocellular, Carcinomas, Cholangiocellular, Cholangiocarcinomas
Narrower concepts tracked separately: Intrahepatic Cholangiocarcinoma
Prevalence
2.5 / 100K
Incidence
1.3 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Cholangiocarcinoma?
BioSniper tracks 5 drugs in development for Cholangiocarcinoma across 4 companies.
How many clinical trials target Cholangiocarcinoma?
There are 34 clinical trials targeting Cholangiocarcinoma tracked by BioSniper.
What is the prevalence of Cholangiocarcinoma?
The estimated prevalence of Cholangiocarcinoma is approximately 2.5 per 100,000 population.